Predictors of Stopping and Starting Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis

Documenti analoghi

• Changes in Use of Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in the U.S. for the period 1983–2009
  di: Kim, Seoyoung C., et al.
  Pubblicazione: (2013)
• Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying anti-rheumatic drug receipt
  di: Polinski, Jennifer M., et al.
  Pubblicazione: (2014)
• Use of Disease-Modifying Medications for Rheumatoid Arthritis by Race and Ethnicity in the National Ambulatory Medical Care Survey
  di: Solomon, Daniel H., et al.
  Pubblicazione: (2012)
• Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study
  di: Yelin, Edward, et al.
  Pubblicazione: (2014)
• Use and Spending on Biologic Disease-modifying Anti-rheumatic Drugs for Rheumatoid Arthritis among U.S. Medicare Beneficiaries
  di: Yazdany, Jinoos, et al.
  Pubblicazione: (2015)